• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PBP
Click for more information
1.38% $2.15

PROBIOTEC LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PBP
Big turnaround happening 		25/03/19 11 1.7K
25/03/19 Last post  Ozibobby Comments Created with Sketch.  11  Views Created with Sketch.  1.7K 
PBP
Ann: Daily share buy-back notice - Appendix 3E 		19/03/19 0 1.1K
19/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  1.1K 
PBP
Ann: Daily share buy-back notice - Appendix 3E 		19/03/19 0 1.3K
19/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  1.3K 
PBP
Ann: Daily share buy-back notice - Appendix 3E 		18/03/19 0 86
18/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  86 
PBP
Ann: Daily share buy-back notice - Appendix 3E 		14/03/19 0 92
14/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  92 
PBP
Ann: Daily share buy-back notice - Appendix 3E 		13/03/19 0 84
13/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  84 
PBP
Ann: Daily share buy-back notice - Appendix 3E 		12/03/19 0 96
12/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  96 
PBP
Ann: Daily share buy-back notice - Appendix 3E 		11/03/19 0 191
11/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  191 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.